Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration.
暂无分享,去创建一个
Srinivas R Sadda | Pearse A Keane | Alexander C Walsh | P. Keane | S. Sadda | S. Liakopoulos | A. Walsh | Tarek Alasil | K. Chang | Sandra Liakopoulos | Karen T Chang | Renu V Jivrajka | Tarek Alasil | R. Jivrajka
[1] Richard F Spaide,et al. INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[2] L. Labree,et al. Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.
[3] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[4] Adnan Tufail,et al. Segmentation error in Stratus optical coherence tomography for neovascular age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[5] Lloyd Paul Aiello,et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. , 2007, Ophthalmology.
[6] Lloyd Paul Aiello. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.
[7] Peter K Kaiser,et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.
[8] Ronald P Danis,et al. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. , 2009, Investigative ophthalmology & visual science.
[9] S. Binder,et al. Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration , 2008, British Journal of Ophthalmology.
[10] G. Wollstein,et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. , 2004, Investigative ophthalmology & visual science.
[11] J. Duker,et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.
[12] A. Loewenstein,et al. VARIABILITY AMONG RETINA SPECIALISTS IN EVALUATING FLUORESCEIN ANGIOGRAMS OF PATIENTS WITH NEOVASCULAR AGERELATED MACULAR DEGENERATION , 2007, Retina.
[13] Paul G. Updike,et al. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[14] E Reichel,et al. Topography of diabetic macular edema with optical coherence tomography. , 1998, Ophthalmology.
[15] F. Holz,et al. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). , 2003, Ophthalmology.
[16] C. Regillo,et al. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.
[17] U Chakravarthy,et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.
[18] Peter K Kaiser,et al. Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. , 2004, Investigative ophthalmology & visual science.
[19] C. Puliafito,et al. Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases. , 2004, Ophthalmology clinics of North America.
[20] Mauricio E Pons,et al. Redefining the limit of the outer retina in optical coherence tomography scans. , 2005, Ophthalmology.
[21] Ziqiang Wu,et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.
[22] Maciej Wojtkowski,et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.
[23] Ronald P Danis,et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. , 2008, Ophthalmology.
[24] L. da Cruz,et al. Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[25] Christopher Kai-shun Leung,et al. Alignment artifacts in optical coherence tomography analyzed images. , 2007, Ophthalmology.
[26] Jennifer I. Lim,et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.
[27] Eric A. Swanson,et al. Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .
[28] J. Duker,et al. A standardized method for reporting changes in macular thickening using optical coherence tomography. , 2005, Archives of ophthalmology.
[29] Robin Ray,et al. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. , 2004, American journal of ophthalmology.
[30] Robert J Zawadzki,et al. Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging. , 2006, Ophthalmology.